DK1218401T3 - 4-Benzylaminoquinolin-konjugat med galdesyre og deres heteroanaloger, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse - Google Patents

4-Benzylaminoquinolin-konjugat med galdesyre og deres heteroanaloger, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse

Info

Publication number
DK1218401T3
DK1218401T3 DK00964126T DK00964126T DK1218401T3 DK 1218401 T3 DK1218401 T3 DK 1218401T3 DK 00964126 T DK00964126 T DK 00964126T DK 00964126 T DK00964126 T DK 00964126T DK 1218401 T3 DK1218401 T3 DK 1218401T3
Authority
DK
Denmark
Prior art keywords
compounds
preparation
heteroanalogs
benzylaminoquinoline
conjugate
Prior art date
Application number
DK00964126T
Other languages
Danish (da)
English (en)
Inventor
Eugen Falk
Martin Bickel
Armin Hofmeister
Heinz-Werner Kleeman
Hans-Willi Jansen
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999145385 external-priority patent/DE19945385A1/de
Priority claimed from DE2000128193 external-priority patent/DE10028193A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1218401T3 publication Critical patent/DK1218401T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
DK00964126T 1999-09-22 2000-09-06 4-Benzylaminoquinolin-konjugat med galdesyre og deres heteroanaloger, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse DK1218401T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999145385 DE19945385A1 (de) 1999-09-22 1999-09-22 Substituierte 4-Benzylaminochinoline und ihre Heteroanlagen, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE2000128193 DE10028193A1 (de) 2000-06-09 2000-06-09 Substituierte 4-Benzylamminochinoline und ihre Heteroanalogen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika, sowie sie enthaltende Medikamente

Publications (1)

Publication Number Publication Date
DK1218401T3 true DK1218401T3 (da) 2004-10-04

Family

ID=26005994

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00964126T DK1218401T3 (da) 1999-09-22 2000-09-06 4-Benzylaminoquinolin-konjugat med galdesyre og deres heteroanaloger, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse

Country Status (26)

Country Link
US (1) US6339077B1 (cs)
EP (1) EP1218401B1 (cs)
JP (1) JP4833471B2 (cs)
KR (1) KR20030010575A (cs)
CN (1) CN1158299C (cs)
AT (1) ATE269352T1 (cs)
AU (1) AU779412B2 (cs)
BR (1) BR0014233A (cs)
CA (1) CA2385445A1 (cs)
CZ (1) CZ2002992A3 (cs)
DE (1) DE50006842D1 (cs)
DK (1) DK1218401T3 (cs)
EE (1) EE200200143A (cs)
ES (1) ES2218222T3 (cs)
HK (1) HK1049169B (cs)
HR (1) HRP20020238A2 (cs)
HU (1) HUP0203045A3 (cs)
IL (1) IL148739A0 (cs)
NO (1) NO20021337L (cs)
NZ (1) NZ517899A (cs)
PL (1) PL353992A1 (cs)
PT (1) PT1218401E (cs)
RU (1) RU2247125C2 (cs)
SK (1) SK3862002A3 (cs)
WO (1) WO2001021642A1 (cs)
YU (1) YU19302A (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
BRPI1009854A2 (pt) * 2009-03-24 2015-08-25 Abbott Lab Processo para preparar composto antiviral
WO2011123693A1 (en) * 2010-04-02 2011-10-06 Senomyx, Inc. Sweet flavor modifier
SG10201606309WA (en) 2011-08-12 2016-09-29 Senomyx Inc Sweet flavor modifier
MX394005B (es) 2014-11-07 2025-03-24 Firmenich Incorporated Acidos 4-amino-5- (ciclohexiloxi) quinolina-3-carboxilicos sustituidos como modificadores del sabor dulce.
US12186329B2 (en) 2018-08-23 2025-01-07 President And Fellows Of Harvard College Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes
EP3890745A4 (en) 2018-12-04 2022-09-14 President and Fellows of Harvard College SYNTHETIC CHOLIC ACID 7-SULPHATE DERIVATIVES AND USES THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
JPH0667846B2 (ja) * 1989-04-28 1994-08-31 一 滝川 利胆剤
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
TW289021B (cs) * 1993-05-08 1996-10-21 Hoechst Ag
IT1274000B (it) * 1994-04-06 1997-07-14 Alfa Wassermann Spa Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
DE4432708A1 (de) 1994-09-14 1996-03-21 Hoechst Ag Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH09315979A (ja) * 1996-05-24 1997-12-09 Tokyo Tanabe Co Ltd 利胆剤
WO1998056757A1 (fr) * 1997-06-11 1998-12-17 Sankyo Company, Limited Derives de benzylamine

Also Published As

Publication number Publication date
JP4833471B2 (ja) 2011-12-07
EP1218401A1 (de) 2002-07-03
RU2247125C2 (ru) 2005-02-27
US6339077B1 (en) 2002-01-15
PT1218401E (pt) 2004-10-29
HRP20020238A2 (en) 2004-04-30
IL148739A0 (en) 2002-09-12
HK1049169B (zh) 2005-04-22
ATE269352T1 (de) 2004-07-15
JP2003510255A (ja) 2003-03-18
HK1049169A1 (en) 2003-05-02
DE50006842D1 (de) 2004-07-22
ES2218222T3 (es) 2004-11-16
CN1374968A (zh) 2002-10-16
NZ517899A (en) 2004-03-26
SK3862002A3 (en) 2003-01-09
NO20021337D0 (no) 2002-03-18
PL353992A1 (en) 2003-12-15
CN1158299C (zh) 2004-07-21
AU779412B2 (en) 2005-01-20
HUP0203045A3 (en) 2004-06-28
KR20030010575A (ko) 2003-02-05
YU19302A (sh) 2004-11-25
HUP0203045A2 (hu) 2003-01-28
CZ2002992A3 (cs) 2002-06-12
NO20021337L (no) 2002-05-15
CA2385445A1 (en) 2001-03-29
AU7515600A (en) 2001-04-24
EE200200143A (et) 2003-04-15
EP1218401B1 (de) 2004-06-16
BR0014233A (pt) 2002-05-21
WO2001021642A1 (de) 2001-03-29

Similar Documents

Publication Publication Date Title
NO20040547L (no) Amino-ftalazinonderivater aktive som kinaseinhibitorer, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende disse.
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
MXPA04012965A (es) Inhibidores virales.
MY142019A (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MY120842A (en) 1,4-benzothiazepine-1, 1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use.
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
NO20052739L (no) CCR5-antagonister som medikamenter
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
MXPA05003253A (es) Nuevos derivados de pirimidinamida y el uso de los mismos.
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
NO20063277L (no) Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav
ID29025A (id) Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DK1218401T3 (da) 4-Benzylaminoquinolin-konjugat med galdesyre og deres heteroanaloger, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
YU43302A (sh) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
JO2733B1 (en) Viral inhibitors
GB9926301D0 (en) Novel compounds
BR0008559A (pt) Aminas tiazol-2-ilideno policìclicas, processos paraa sua preparação e seu emprego comomedicamento
NO20072090L (no) Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav II